Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first‐line regimen for Helicobacter pylori eradication: A randomized controlled trial
Sign Up to like & getrecommendations! Published in 2022 at "Helicobacter"
DOI: 10.1111/hel.12935
Abstract: Due to general unavailability and common side effects of tetracycline, the clinical application of bismuth quadruple therapy (BQT) is greatly limited. Whether amoxicillin can replace tetracycline in BQT remains unknown. This study aimed to compare… read more here.
Keywords: regimen helicobacter; first line; pylori eradication; line regimen ... See more keywords
Gemcitabine, docetaxel, and capecitabine (GTX) as a first-line regimen in metastatic pancreatic adenocarcinomas (mPAC): A single institution experience.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.4_suppl.385
Abstract: 385 Background: After decades of minimal to no therapeutic options, Gemcitabine emerged as the only safe & effective frontline regimen for mPAC. A 3-drug combination regimen, GTX, first optimized by Fine et al in 2009… read more here.
Keywords: experience; gtx; line regimen; first line ... See more keywords
Update results of paclitaxel and cisplatin in combination with anlotinib as first-line regimen for advanced esophageal squamous cell carcinoma (ESCC): A multicenter, single-arm, open-label phase Ⅱ clinical trial.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.3_suppl.181
Abstract: 181Background: The prognosis of pts with advanced ESCC remains dismal clinically. Paclitaxel and cisplatin were used as the standard first-line regimen in ESCC for almost two decades. As a novel mu... read more here.
Keywords: update results; paclitaxel cisplatin; line regimen; results paclitaxel ... See more keywords
Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study
Sign Up to like & getrecommendations! Published in 2018 at "Frontiers in Public Health"
DOI: 10.3389/fpubh.2018.00063
Abstract: Background Assessment of virological outcomes among HIV-infected patients receiving protease (PR) inhibitor-based second-line regimen are uncommon in Cambodia. The objective of this study is to assess the virological effectiveness of this regimen as well as… read more here.
Keywords: inhibitor based; line; line regimen; study ... See more keywords